PC-SPES inhibits colon cancer growth in vitro and in vivo

Cancer Research

Volumn 62, Issue 18, 2002, Pages 5204-5209

  Huerta, Sergio ^a   Arteaga, James R ^a   Irwin, Ronald W ^a   Ikezoe, Takayuki ^b   Heber, David ^a   Koeffler, H Phillip ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BETA TUBULIN; CARBOXYMETHYLCELLULOSE; HERBACEOUS AGENT; PC SPES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL LINE; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLON POLYP; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; SCORING SYSTEM; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; BODY WEIGHT; CELL DIVISION; COLONIC NEOPLASMS; COLONIC POLYPS; DRUGS, CHINESE HERBAL; EATING; ESTROGENS; FEMALE; GROWTH INHIBITORS; HUMANS; MICE; MICE, INBRED C57BL; PHYTOTHERAPY; PLANT EXTRACTS; TUMOR CELLS, CULTURED;

EID: 0037105650     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Unconventional medicine in the United States. Prevalence, costs, and patterns of use
2. Cancer patients’ use of nonproven therapy: A 5-year follow-up study
3. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer
4. Mechanism of action of herbal supplement PC-SPES: Elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells
5. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest
6. PC-SPES a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo
7. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer
8. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: A preliminary investigation on human cell lines and patients
9. In vitro mechanism of PC SPES
10. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers
11. Identification of FAP locus genes from chromosome 5q21
12. Association of the APC tumor suppressor protein with catenins
13. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin
14. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
15. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam
16. Aspirin prevents tumors in a murine model of familial adenomatous polyposis
17. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice
18. Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: Kinetics, strain effects and resistance to chemosuppression
19. min mouse
20. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice
21. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor
22. Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis
23. Shortchain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice
24. min mouse
25. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice
26. Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule
27. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
28. Expression of Fas ligand by human gastric adenocarcinomas: A potential mechanism of immune escape in stomach cancer
29. Expression of estrogen receptor (ER)-a and ER-β in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation
30. PC-SPES diminishes the anti-tumor effects of paclitaxel in androgen independent human prostate cancer xenografts and downregulates tubulin expression
31. 2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines
32. Estrogen receptor β mRNA in colon cancer cells: Growth effects of estrogen and genistein
33. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth
34. Manipulation of the mouse germline in the study of Min-induced neoplasia
35. Validation of a model of colon cancer progression